Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
,
Lung Cancer
Opdivo-Yervoy First Immunotherapy Combo Approved for First-Line Therapy of Patients with Metastatic NSCLC
Read More
From the Literature
,
Lung Cancer
First-Line Osimertinib Therapy Boosts Overall Survival in Non–Small-Cell Lung Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
Case Reports
,
Immunotherapy
,
Lung Cancer
Rapid Onset of Severe Transaminitis in a Patient with Non–Small-Cell Lung Cancer After First Dose of Nivolumab 480 mg
Matthew Stankowicz, PharmD, BS
,
Megan Banaszynski, PharmD, BCOP
,
Russell Crawford, RPh, BCOP
Matthew Stankowicz, PharmD, BS; Megan Banaszynski, PharmD, BCOP; Russell Crawford, RPh, BCOP
Read More
Lung Cancer
,
Thyroid Cancer
,
FDA Oncology Update
FDA Grants Priority Review to New Drug Application for the RET Kinase Inhibitor Selpercatinib
Read More
Lung Cancer
Long-Term Data Confirm Survival Benefit for Pembrolizumab in Advanced NSCLC
Phoebe Starr
Read More
Leukemia
,
Lung Cancer
,
Lymphoma
,
FDA Oncology Update
November 25, 2019 – Oncology News & Updates
Read More
FDA Updates
,
Lung Cancer
Lorbrena (Lorlatinib) Approved for the Treatment of Metastatic Non–Small-Cell Lung Cancer with ALK Mutation
Loretta Fala, Medical Writer
Read More
FDA Updates
,
Lung Cancer
Vizimpro (Dacomitinib) Approved for First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer with EGFR Mutation
Loretta Fala, Medical Writer
Read More
Lung Cancer
,
FDA Oncology Update
April 16, 2019 – FDA Approvals, News & Updates
Yvette Florio Lane
Read More
Lung Cancer
,
FDA Oncology Update
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Yvette Florio Lane
Read More
8
9
10
11
12
Page 11 of 12
Results 101 - 110 of 114